/ By Ilan Shavit /
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
Recently announced twelve teams have been selected as finalists for the first competition in their US $2.25 million Nokia Sensing XCHALLENGE, intended to be two separate and consecutive competitions to advance innovative sensing technologies that capture meaningful data about a consumer’s health and surrounding environment.
Advancements in sensing technology resulting from this competition may help lay foundations for a mobile health revolution that transforms healthcare into a system that is highly personalized, instantly accessible and relevant to the medical needs of every person.
One of the twelve finalists chosen is Israeli medical device startup Elfi-Tech, which is a distinct feather in the cap for the small Israeli firm. Founded in 2006 by Dr. Ilya Fine, Elfi-Tech has developed innovative non-invasive optical technology based on Dynamic Light Scattering (DLS). Using this novel technique, the device can continuously and non-invasively measure skin blood flow, blood velocity, coagulation and vascular aging in addition to already existing parameters like pulse and motion.
Elfi-Tech’s mDLS ™ sensor is easily deployed, simple to operate and robust. Its raw signals translate into novel indices of cardiovascular risks: endothelial function, global coagulation status of the blood, a measurement of Red Blood Cells (RBCs) aggregation rate, and fibrinogen concentration in blood. The mDLS sensor is then combined with advanced algorithms to interpret data and provide accurate monitoring of physiological parameters.
In addition, by intensively analyzing the high-resolution blood pulse wave, the sensor can continuously and non-invasively measure a set of physiological parameters such as respiratory rate, systolic blood pressure trends, cardiac contractility, cardiac valve dysfunction and Traube-Hering-Mayer oscillations. Utilizing this information, the platform can detect health perturbations related to cardiac, vascular, respiratory and neurological pathologies.
XPRIZE is a non-profit organization that designs and manages public competitions intended to encourage technological development that could benefit mankind.
The XPRIZE mission is to bring about “radical breakthroughs for the benefit of humanity” through incentivized competition. It fosters high-profile competitions that motivate individuals, companies and organizations across all disciplines to develop innovative ideas and technologies that help solve the grand challenges that restrict humanity’s progress.
XPRIZE conducts competitions in five Prize Groups: education, exploration, energy & environment, global development; and life sciences. Current prize competitions include the $30 million Google Lunar XPRIZE, the $10 million Archon Genomics XPRIZE presented by Express Scripts, the $10 million Qualcomm Tricorder XPRIZE, and of course the $2.25 million Nokia Sensing XCHALLENGE.
Nokia is a global leader in mobile communications whose products have become an integral part of the lives of people around the world. Every day, more than 1.3 billion people use their Nokia phones to capture and share experiences, access information, find their way or simply to speak to one another.
The winner of the prize will ultimately be announced in July of 2014.